S&P 500 Futures
(0.11%) 5 301.50 points
Dow Jones Futures
(0.09%) 38 824 points
Nasdaq Futures
(0.24%) 18 636 points
Oil
(0.16%) $77.11
Gas
(3.87%) $2.69
Gold
(0.01%) $2 346.10
Silver
(-0.48%) $30.30
Platinum
(-0.23%) $1 039.60
USD/EUR
(0.03%) $0.922
USD/NOK
(-0.03%) $10.48
USD/GBP
(0.08%) $0.786
USD/RUB
(-0.94%) $89.58

Realtime updates for CryoLife Inc [CRY]

Exchange: NYSE Sector: Healthcare Industry: Medical - Devices
Last Updated24 Jan 2022 @ 00:00

1.42% $ 17.88

Live Chart Being Loaded With Signals

Commentary (24 Jan 2022 @ 00:00):

Artivion Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide. It offers BioGlue, a polymer consisting of bovine blood protein and an agent for cross-linking proteins for cardiac, vascular, pulmonary, and general surgical applications; On-X prosthetic aortic and mitral heart valve, and On-X ascending aortic prosthesis; cardiac preservation services; PhotoFix, a bovine pericardial patch; and E-vita OPEN PLUS and E-vita OPEN NEO, a hybrid stent graft system...

Stats
Today's Volume 257 460
Average Volume 200 073
Market Cap 725.15M
EPS $-0.513 ( 2022-02-09 )
Last Dividend $0.0300 ( 2015-12-09 )
Next Dividend $0 ( N/A )
P/E 425.71
ATR14 $0.701 (3.92%)
Insider Trading
Date Person Action Amount type
2021-06-01 Salveson Jon W Buy 4 423 Common Stock
2021-06-01 Morgan Harvey Buy 4 423 Common Stock
2021-06-01 Burbank Jeffrey H Buy 4 423 Common Stock
2021-04-30 Horton Amy Buy 2 700 Common Stock
2021-04-30 Horton Amy Sell 2 700 Common Stock
INSIDER POWER
0.00
Last 100 transactions
Buy: 1 202 389 | Sell: 548 438

Volume Correlation

Long: -0.18 (neutral)
Short: -0.10 (neutral)
Signal:(36.808) Neutral

CryoLife Inc Correlation

10 Most Positive Correlations
10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

CryoLife Inc Correlation - Currency/Commodity

The country flag -0.56
( weak negative )
The country flag -0.60
( weak negative )
The country flag 0.39
( neutral )
The country flag -0.68
( moderate negative )
The country flag 0.50
( neutral )

CryoLife Inc Financials

Annual 2023
Revenue: $354.00M
Gross Profit: $213.98M (60.45 %)
EPS: $-0.750
FY 2023
Revenue: $354.00M
Gross Profit: $213.98M (60.45 %)
EPS: $-0.750
FY 2022
Revenue: $313.79M
Gross Profit: $202.52M (64.54 %)
EPS: $-0.480
FY 2021
Revenue: $298.84M
Gross Profit: $197.51M (66.09 %)
EPS: $-0.392

Financial Reports:

No articles found.

CryoLife Inc Dividends

(Q3/22) (Q4/22) (Q1/23) (Q2/23) (Q3/23) (Q4/23) (Q1/24) (Q2/24) (Q3/24) (Q4/24)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)

CryoLife Inc Dividend Information - Ex Dividend Junior

Dividend Sustainability Score: 5.02 - average (34.67%) | Divividend Growth Potential Score: 0 - No dividend growth expected in the near future
Information
First Dividend $0.0250 2012-09-12
Last Dividend $0.0300 2015-12-09
Next Dividend $0 N/A
Payout Date 2015-12-18
Next Payout Date N/A
# dividends 14 --
Total Paid Out $0.395 --
Avg. Dividend % Per Year 0.00% --
Score 2.33 --
Div. Sustainability Score 5.02
Div.Growth Potential Score 0
Div. Directional Score 2.30 --
Next Divdend (Est)
(2024-06-20)
$0 Estimate 0.00 %
Dividend Stability
0.06 Very Bad
Dividend Score
2.33
Pay Frequency
Quarterly
Yearly Payout
Year Amount Yield
2012 $0.0500 1.04%
2013 $0.108 1.61%
2014 $0.118 1.06%
2015 $0.120 1.07%
2016 $0 0.00%
2017 $0 0.00%
2018 $0 0.00%
2019 $0 0.00%
2020 $0 0.00%
2021 $0 0.00%
2022 $0 0.00%
2023 $0 0.00%
2024 $0 0.00%

Dividend Commentary

With a moderate Dividend Sustainability Score (DSS), the company may sustain its dividends, but continuous monitoring is advised for any financial shifts. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.

Top 10 dividend Companies for NYSE

Symbol Title Last dividend Frequency Years Dividend Yearly Dividend Score
LOMA Dividend King 2023-06-30 Quarterly 2 5.23% 8.53
ARR Dividend Royal 2024-05-14 Monthly 15 11.08% 8.50
ACV Dividend Royal 2024-06-13 Monthly 10 10.19% 8.50
PVL Dividend Royal 2023-11-15 Monthly 14 9.37% 8.50
ACP Dividend Royal 2024-05-22 Monthly 14 11.88% 8.50
AVK Dividend Royal 2024-05-14 Monthly 22 9.54% 8.31
AFG Dividend Royal 2024-04-12 Bi-Monthly 39 9.39% 8.06
JPT Dividend King 2023-11-02 Monthly 8 4.19% 8.05
VCIF Dividend Royal 2023-08-18 Monthly 6 8.05% 8.02
EDI Dividend Royal 2023-12-07 Monthly 13 8.85% 7.94

Dividend Sustainability Score (DSS)

RatioActual ValueWeightNormalized ValueScoreRange
netProfitMarginTTM-0.02611.500-0.523-0.784[0 - 0.5]
returnOnAssetsTTM-0.01231.200-0.409-0.491[0 - 0.3]
returnOnEquityTTM-0.03401.500-1.489-2.23[0.1 - 1]
payoutRatioTTM0-1.00000[0 - 1]
currentRatioTTM4.950.80010.008.00[1 - 3]
quickRatioTTM2.790.80010.008.00[0.8 - 2.5]
cashRatioTTM1.1151.5004.917.37[0.2 - 2]
debtRatioTTM0.404-1.5003.27-4.91[0 - 0.6]
interestCoverageTTM1.2921.000-0.633-0.633[3 - 30]
operatingCashFlowPerShareTTM0.2242.009.9310.00[0 - 30]
freeCashFlowPerShareTTM0.02522.009.9910.00[0 - 20]
debtEquityRatioTTM1.073-1.5005.71-8.56[0 - 2.5]
grossProfitMarginTTM0.6371.0002.722.72[0.2 - 0.8]
operatingProfitMarginTTM0.09481.000-0.104-0.104[0.1 - 0.6]
cashFlowToDebtRatioTTM0.02921.000-0.949-0.949[0.2 - 2]
assetTurnoverTTM0.4700.800-0.202-0.162[0.5 - 2]
Total Score5.02

Dividend Growth Score (DGS)

RatioActual ValueWeightNormalized ValueScoreRange
peRatioTTM-101.241.000-10.000[1 - 100]
returnOnEquityTTM-0.03402.50-0.957-2.23[0.1 - 1.5]
freeCashFlowPerShareTTM0.02522.009.9910.00[0 - 30]
dividendYielPercentageTTM01.50000[0 - 0.4]
operatingCashFlowPerShareTTM0.2242.009.9310.00[0 - 30]
payoutRatioTTM01.50000[0 - 1]
pegRatioTTM-14.721.500-10.000[0.5 - 2]
operatingCashFlowSalesRatioTTM0.02511.000-1.8730[0.1 - 0.5]
Total Score-0.427

CryoLife Inc Options Data

Calls

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Puts

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

CryoLife Inc

Artivion Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide. It offers BioGlue, a polymer consisting of bovine blood protein and an agent for cross-linking proteins for cardiac, vascular, pulmonary, and general surgical applications; On-X prosthetic aortic and mitral heart valve, and On-X ascending aortic prosthesis; cardiac preservation services; PhotoFix, a bovine pericardial patch; and E-vita OPEN PLUS and E-vita OPEN NEO, a hybrid stent graft system. The company also provides E-xtra DESIGN ENGINEERING products for the treatment of aortic vascular diseases; E-nside, an off-the-shelf stent graft for the treatment of thoraco-abdominal disease; E-vita THORACIC 3G for the endovascular treatment of thoracic aortic aneurysms; E-nya, a thoracic stent graft system for the minimally invasive repair of lesions of the descending aorta; E-ventus BX, a balloon-expandable peripheral stent graft for the endovascular treatment of renal and pelvic arteries; E-liac to treat aneurysmal iliac arteries, and aneurysmal iliac side branches; and E-tegra, an abdominal aortic aneurysms stent graft system. In addition, it offers synthetic vascular grafts for use in open aortic and peripheral vascular surgical procedures; PerClot, an absorbable powdered hemostat for use in surgical procedures; and cardiac laser therapy products, such as SolarGen 2100s Console and SoloGrip III disposable handpieces. Further, the company sells CryoVein femoral vein and CryoArtery femoral artery vascular preservation services; CarbonAid CO2 diffusion catheters and Chord-X ePTFE sutures for mitral chordal replacement; and ascyrus medical dissection stents, as well as offers pyrolytic carbon coating services to other medical device manufacturers. The company serves physicians, hospitals, and other healthcare facilities, as well as cardiac, vascular, thoracic, and general surgeons. The company was formerly known as CryoLife, Inc. and changed its name to Artivion Inc. in January 2022. Artivion Inc. was founded in 1984 and is headquartered in Kennesaw, Georgia.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators

Total Execution Time: 2.3238229751587 seconds
Number of API calls: 2
Number of DB calls: 8